News Center

Home page

Peak Report

News reports

Beirunning Appears at Zhejiang Ophthalmology Annual Meeting

Release time:

2020-07-22

Beirunning Appears at Zhejiang Ophthalmology Annual Meeting

News 11# July 15 - 17 , Zhejiang Institute of Integrated Traditional Chinese and Western Medicine Ophthalmology Annual Meeting Held in Huzhou, Zhejiang Province. Peak Pharmaceutical Company brought its products to the annual meeting and introduced Beirunning (Olopatadine Hydrochloride Eye Drops), the first domestic product that passed the consistency evaluation.

This annual meeting is co-sponsored by the Visual Function Professional Committee of Zhejiang Rehabilitation Medicine Association, the Ophthalmology Professional Committee of Zhejiang Integrative Medicine Association, and the Ophthalmology Professional Committee of Huzhou Medical Association. It is hosted by Zhejiang Hospital. There are mainly national continuing medical education class "New Progress in Diagnosis and Treatment of Visual Function Rehabilitation", and provincial continuing medical education class "Diagnosis and Treatment of Difficult Ophthalmology Diseases by Traditional Chinese and Western Medicine", the provincial continuing medical education class "integrated traditional Chinese and western medicine prevention and treatment of diabetic retinopathy seminar" and other content.

. At this annual meeting, the pharmaceutical company invited Zhang Huicheng, president of Hangzhou Qiushi Hospital and former president of the ophthalmology annual meeting of Zhejiang Integrated Traditional Chinese and Western Medicine Association, to introduce Jianfeng Pharmaceutical and Berunning products. He introduced in detail the causes of allergy, how to choose anti-eye allergy drugs, why to choose anti-allergy drugs with double-effect mechanism, and why to choose Berunning Olopatadine Hydrochloride Eye Drops of Zhejiang Jianfeng Pharmaceutical Co., Ltd. Beirunning is the first eye drops that have passed the consistency evaluation in China, and with its unique efficacy of antagonizing histamine H1- receptors, stabilizing mast cells and two-way anti-allergy has received widespread attention. Beirunning in the treatment of children with allergic conjunctivitis has good effect, fast curative effect, will not cause significant mast cell degranulation, so the use of more safe, and almost no adverse reactions to the eye tissue, is the current treatment of allergic conjunctivitis an ideal drug. Beirunning products have been unanimously recognized and praised by on-site ophthalmologists.

Participating in this annual meeting has improved the recognition of Berunning in Zhejiang ophthalmologists and laid a good foundation for the market promotion of Berunning in the later period. (Lin Xu)

More information

2022 China's Top 100 Building Materials Enterprises 2022 China's Top 100 Cement Clinker Production Capacity Peak even on two authoritative lists

In March, the authoritative organization of the cement industry successively released two series of lists of China's top 500 building materials enterprises in 2022 and China's top 100 cement clinker production capacity in 2022. Jianfeng Group ranked among the "top 100" in the two lists ". The list of China's top 500 building materials enterprises was officially released in early March. This series of lists was selected by the China Building Materials Enterprise Management Association. Through more than 20 years of comprehensive data research on China's building materials industry, referring to international practices, the rankings are based on the company's annual operating income., Cement products, building ceramics, waterproof materials, aluminum-plastic profiles, coatings, glass, building materials equipment manufacturing and other sub-industries related to building materials. Jianfeng Group ranks 96th among the companies on the list and 27th among the cement manufacturers on the list. On March 16, the awarding ceremony of 2022 China's top 100 cement clinker production capacity list was held in Hangzhou. This series of lists is released by China Cement Network, an authoritative organization in China's cement industry. The ranking is based on the total production capacity (excluding the production capacity of other kiln types and grinding stations) of new dry clinker production lines completed and put into operation by Chinese cement enterprises in China as of December 31, 2022. The data statistics are calculated based on the design production capacity and 310 days of annual operation. Jianfeng Group ranked 53rd with an annual design capacity of 3.627 million tons. (this newspaper reporter)

2023

03-21

Company sends off retired employees

On the morning of February 22, the trade union of the group company held a simple and warm farewell party for retired employees in 2021-2022. More than 50 retired employees gathered together to discuss and exchange with Jiang Xiaomeng and other group leaders.

2023

03-04

On the first day of the new year, group leaders went to the grassroots level.

On January 29, the first day of work after the Spring Festival holiday, the leaders of the group company made a video connection to subordinate enterprises stationed abroad, and separately visited the gold enterprises to learn about the resumption of work and put forward requirements for the implementation of the work plan for the new year.

2023

02-17

Group Companies Commend 2022 Advanced

On the morning of January 18, the group company held the 2022 annual summary commendation meeting to review the work of the previous year, make arrangements for the work in 2023, sign the 2023 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2022 advanced collectives and individuals.

2023

01-29

Jiang Xiaomeng re-elected chairman of the Municipal Federation of Industry and Commerce

On December 24, 2022, the Jinhua Federation of Industry and Commerce (General Chamber of Commerce) held the seventh member representative meeting. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, was re-elected as the chairman of the Municipal Federation of Industry and Commerce at this meeting.

2023

01-12

Peak Pharmaceutical Donates Epidemic Prevention Materials

Since the optimization and adjustment of the new crown infection epidemic management policy, there has been an explosive growth of infected people in the country, and the pressure on the supply of related materials has increased sharply. Before and after New Year's Day, the company has twice organized epidemic prevention materials, through the Jinhua City Charity Federation, Jinhua City Economic and Technological Development Zone Charity Federation targeted donations, a total value of more than 200,000 yuan.

2023

01-12

< 1 2 3 4...61 > 跳转到页